432545-63-6 (甲氨蝶呤D3,Methotrexate-d)

甲氨蝶呤-d3;[ 2H3 ] - 甲氨蝶呤标准品;N-[4-[[(2,4-二氨基-6-蝶啶基)甲基]甲基-D3-氨基]苯甲酰基]-L-谷氨酸;氨甲喋呤-D3 标准品;甲氨蝶呤D3;甲氨蝶呤 d3;

L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]- (9CI);Methotrexate-d3;Methotrexate-d3 Heptaglutamate;Methotrexate-D3 solution;Methotrexate-d;HY-14519S;MS-28347;L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-(9ci);DTXSID90962981;432545-63-6;Methotrexate-D? (100?g/mL in Methanol with 1% 0.1N NaOH);CS-0109156;N-(4-{[(4-Amino-2-imino-2,3-dihydropteridin-6-yl)methyl][(~2~H_3_)methyl]amino}benzoyl)glutamic acid;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-(trideuteriomethyl)amino]benzoyl]amino]pentanedioic acid;Methotrexate-d3, Technical Grade 85per cent;1ST10175;DB-266048;N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-l-glutamic acid;Methotrexate D3;Methotrexate-D3; L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-; N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methyl-d3-amino]benzoyl]-L-glutamic acid;

FBOZXECLQNJBKD-FUPFOCIHSA-N

1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1/i1D3

OC([C@H](CCC(=O)O)NC(C1C=CC(=CC=1)N(C([2H])([2H])[2H])CC1C=NC2=C(C(N)=NC(N)=N2)N=1)=O)=O

200-659-6